Some Transmission of SARS-CoV-2 Occurs After Seven, 10 Days
TUESDAY, Jan. 5, 2021 -- There is some onward transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from household contacts released from quarantine after seven or 10 days, according to research published in the Jan. 1 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Melissa A. Rolfes, Ph.D., from the CDC COVID-19 Response Team, and colleagues analyzed interim data from an ongoing study of household transmission of SARS-CoV-2 to examine the proportion of household contacts who had detectable virus after a shortened quarantine period. For 14 days, household contacts of index patients completed a daily symptom diary and self-collected respiratory specimens, which were tested for SARS-CoV-2.
The researchers found that 59 percent of the 185 household contacts had detectable SARS-CoV-2 at any time; 76 and 86 percent of test results were positive within seven and 10 days, respectively, after the index patient's illness onset date. The chance of remaining asymptomatic and receiving negative test results through day 14 was 81 and 93 percent, respectively, among household contacts who received negative SARS-CoV-2 test results and were asymptomatic through day 7 or through day 10.
"Although persons might be more adherent to a shorter quarantine period, such a policy is not without risk for further spread," the authors write. "Timely access to a sufficiently sensitive test at the end of a shorter quarantine period will help identify household contacts with SARS-CoV-2 infection."

© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
Read this next
Cancer Screening, Diagnoses Down During Early Pandemic
FRIDAY, Jan. 22, 2021 -- There was a significant decrease in the number of patients undergoing screening tests for cancer and in the number of resulting diagnoses of cancerous and...
Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
FRIDAY, Jan. 22, 2021 -- Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome...
Total Pediatric ED Visits Decreased in 2020 Versus 2018, 2019
FRIDAY, Jan. 22, 2021 -- There was a decrease in the total number of pediatric emergency department visits in 2020, but the proportion of trauma-related visits increased,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.